Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,774.50
Ask: 1,775.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.056%)
Open: 1,775.50
High: 1,778.50
Low: 1,769.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday preview: BoJ, GlaxoSmithKline and Next in the spotlight

Tue, 30th Oct 2018 16:23

(Sharecast News) - Barring surprises, the focus on Wednesday will likely be on the Bank of Japan's monetary policy meeting, with traders scanning the headlines for any whiff of any potential near-term shifts in its policy settings.That is especially pertinent for global financial markets given the ongoing grind higher in US interest rates and the looming end of the European Central Bank's bond purchase programme, come December.The consensus is for the BoJ to stay put, but for analysts at Bank of America-Merrill Lynch there was some risk of an "early adjustment" due to financial stability concerns.Thus, their recommendation to investors was simple: " watch the language on this topic in the Outlook Report.""While financial stability concerns may become a bigger topic down the road, the majority of the board places a greater weight on the price stability mandate at the moment," economists at BofA-ML said."We think the BoJ leadership will continue advocating the use of macro-prudential tools, not rate adjustments, to address emerging financial stability concerns while also stressing the need for structural reforms in the banking sector."Stateside meanwhile, in the run-up to Friday's monthly US non-farm payrolls report, the spotlight will be on consultancy ADP's private sector jobs report for October at 1215 GMT.Across the Channel, a barrage of usually outdated readings on the likes of Spanish and Austrian third quarter GDP or euro area unemployment in September will garner more attention this time around in the wake of Tuesday's unexpectedly weak preliminary reading on third quarter GDP at the Eurozone level. GlaxoSmithKline is among the companies set to update markets on Wednesday.UBS is forecasting the pharmaceuticals maker will announce third quarter sales of £8.03bn, for core operating profits of £2.40bn and core earnings per share of 33.0p.In particular, the Swiss broker said it would be watching to see how its new products were supporting the company's long-term growth forecasts, especially Trelegy and Shingrix, which it said together accounted for roughly 60% of the top line growth it forecast for the company over 2017-2022.Analyst Michael Leuchten expected sales from Trelegy to printat £56m and those for Tivicay to come in at £695m. Fashion retailer Next was also scheduled to update markets with UBS having penciled-in full-price sales growth of 2% for the third quarter, partly on the back of positive seasonal factors relative to the last quarter of the year.Nevertheless, warmer weather may have impacted on the company's sales of outerwear, the broker said.In terms of the main 'talking points' to watch out for in the company's trading statement, analyst Andrew Hughes pointed to: "the runway for growth from The Label and International, the potential benefit from industry capacity reduction, and the ongoing impact from channel shift (both stores to online, and Next branded ranges to Label)."Wednesday October 31INTERIM DIVIDEND PAYMENT DATE888 Holdings, Essentra, NAHL Group, Smith & Nephew, STV Group, Wynnstay GroupQUARTERLY PAYMENT DATEF&C Commercial Property Trust Ltd., F&C Private Equity Trust, Funding Circle SME Income Fund, Middlefield Canadian Income PCC, Schroder Income Growth FundINTERNATIONAL ECONOMIC ANNOUNCEMENTSChicago PMI (US) (13:45)Crude Oil Inventories (US) (14:45)MBA Mortgage Applications (US) (11:00)Retail Sales (GER) (06:00)Unemployment Rate (EU) (10:00)Q3Gem Diamonds Ltd. (DI), GlaxoSmithKline, Next, Smurfit Kappa Group, Standard CharteredEGMSVietNam Holding LtdAGMSAEW UK Long Lease Reit , Brooks Macdonald Group, Defenx, JPMorgan Global Growth & Income, Maxcyte (DI), Pantheon International , Rainbow Rare Earths Limited NPV, VietNam Holding LtdTRADING ANNOUNCEMENTSComputacenter, Gem Diamonds Ltd. (DI), Just Group, Next, PPHE Hotel Group Ltd, River and Mercantile Group , Riverstone Energy Limited , Watkin JonesUK ECONOMIC ANNOUNCEMENTSGFK Consumer Confidence (00:01)FINAL DIVIDEND PAYMENT DATEAbbey, Alumasc Group, Beeks Financial Cloud Group, Pembroke Vct, Pembroke Vct B, Standard Life UK Smaller Companies Trust
More News
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.